Your browser doesn't support javascript.
loading
Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric study.
Huang, Florent; Khellaf, Lucas Rémi; Lefèvre, Guillaume; Berti, Alvise; d'Humières, Thomas; Sionis, Alessandro; Solé, Albert Ariza; Bello, Federica; Bermeo Garrido, Juan Andres; Crickx, Etienne; Delvino, Paolo; Emmi, Giacomo; Gaillet, Antoine; Garcia, Gilles; Gavand, Pierre-Edouard; George, Jean-Louis; Gilles, Floriane; Golden, Cécile; de Groote, Pascal; Guffroy, Aurélien; Martis, Nihal; Monti, Sara; Mourlanette, Pierre; Pineton de Chambrun, Marc; Prunier, Fabrice; Regola, Francesca; Seret, Gabriel; Terrier, Benjamin; Tréfond, Ludovic; Souteyrand, Géraud; Varenne, Olivier; Zilio, Filippo; Haziza, Franck; Benamer, Hakim; Kahn, Jean-Emmanuel; Vallée, Alexandre; Groh, Matthieu.
Affiliation
  • Huang F; ACTION Study Group, Department of Cardiology, Foch Hospital, Suresnes, France; French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France.
  • Khellaf LR; French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France.
  • Lefèvre G; French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France; Department of Internal Medicine and Clinical Immunology, University of Lille, CHU de Lille, Lille, France; Inserm U1286 Institute for Translational Research in Inflamma
  • Berti A; Center for Medical Sciences, Department of Cellular, Computational, and Integrative Biology, University of Trento, Trento, Italy; Rheumatology Unit, Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari Trento, Trento, Italy.
  • d'Humières T; Physiology Department, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France.
  • Sionis A; Intensive Cardiac Care Unit, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Solé AA; Intensive Cardiac Care Unit, Cardiology Department, Bellvitge University Hospital, Bioheart, Grup de Malalties Cardiovasculars, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Bello F; Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy; Interdisciplinary Internal Medicine Unit, Behçet Centre and Lupus Clinic, AOU Careggi Hospital of Firenze, Firenze, Italy.
  • Bermeo Garrido JA; Intensive Cardiac Care Unit, Cardiology Department, Bellvitge University Hospital, Bioheart, Grup de Malalties Cardiovasculars, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Crickx E; Internal Medicine Department, Centre National de Référence des Cytopénies Auto-immunes de l'Adulte, Hôpital Henri Mondor, Fédération Hospitalo-Universitaire Innovative Therapy for Immune Disorders, Assistance Publique Hôpitaux de Paris, Université Paris Est Créteil, Créteil, France.
  • Delvino P; Department of Internal Medicine and Therapeutics, Università di Pavia, Pavia, Italy; Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Emmi G; Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy; Interdisciplinary Internal Medicine Unit, Behçet Centre and Lupus Clinic, AOU Careggi Hospital of Firenze, Firenze, Italy; Centre for Inflammatory Diseases, Department of Medicine, Monash Medical Centre, Monash
  • Gaillet A; French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France; Medical Intensive Care Unit, Hôpitaux Universitaires Henri Mondor, Assistance Publique Hôpitaux de Paris, Créteil, France.
  • Garcia G; Department of Pulmonology, Antony Private Hospital, Antony, France.
  • Gavand PE; Internal Medicine, Clinique Rhéna, Strasbourg, France.
  • George JL; Department of Cardiology, Centre Hospitalier de Versailles, André Mignot Hospital, Le Chesnay-Rocquencourt, France.
  • Gilles F; Department of Cardiology, Centre Hospitalier de Versailles, André Mignot Hospital, Le Chesnay-Rocquencourt, France.
  • Golden C; Internal Medicine, Vesoul Hospital, Vesoul, France.
  • de Groote P; French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France; CHU Lille, Service de Cardiologie, Lille, France; Inserm U1167, Institut Pasteur de Lille, Lille, France.
  • Guffroy A; Department of Clinical Immunology and Internal Medicine, National Reference Center for Systemic Autoimmune Diseases (CNR RESO), Tertiary Center for Primary Immunodeficiencies, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Martis N; Internal Medicine Department, Hôpital de Larchet, University Hospital of Nice, Côte d'Azur University, Nice, France.
  • Monti S; Department of Internal Medicine and Therapeutics, Università di Pavia, Pavia, Italy.
  • Mourlanette P; Clinique des Cèdres, Château Alliez, Cornebarrieu, France.
  • Pineton de Chambrun M; Department of Intensive Care Medicine, APHP, Sorbonne Université, Pitié Salpétrière, Paris, France.
  • Prunier F; Department of Cardiology, Universitary Hospital of Angers, Angers, France.
  • Regola F; Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia, Italy.
  • Seret G; Department of Cardiology, University of Sorbonne-Paris Cité, APHP, Cochin Hospital, Paris, France.
  • Terrier B; Department of Internal Medicine, Hôpital Cochin, APHP, Paris, France.
  • Tréfond L; Internal Medicine, Gabriel Montpied Hospital, Clermond-Ferrand, France.
  • Souteyrand G; Department of Cardiology, Gabriel Montpied Hospital, Clermond-Ferrand, France.
  • Varenne O; Department of Cardiology, University of Sorbonne-Paris Cité, APHP, Cochin Hospital, Paris, France.
  • Zilio F; Department of Cardiology, Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari Trento, Trento, Italy.
  • Haziza F; ACTION Study Group, Department of Cardiology, Foch Hospital, Suresnes, France.
  • Benamer H; ACTION Study Group, Department of Cardiology, Foch Hospital, Suresnes, France.
  • Kahn JE; French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
  • Vallée A; Department of Epidemiology and Public Health, Foch Hospital, Suresnes, France.
  • Groh M; French National Reference Center for Hypereosinophilic Syndromes, Department of Internal Medicine, Foch Hospital, Suresnes, France. Electronic address: m.groh@hopital-foch.com.
J Allergy Clin Immunol Pract ; 12(5): 1377-1381.e2, 2024 May.
Article in En | MEDLINE | ID: mdl-38307204

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recurrence / Coronary Vasospasm / Eosinophilia Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Allergy Clin Immunol Pract Year: 2024 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recurrence / Coronary Vasospasm / Eosinophilia Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: J Allergy Clin Immunol Pract Year: 2024 Type: Article Affiliation country: France